Search Prime Grants

P20GM139760

Project Grant

Overview

Grant Description
Delaware Center for Musculoskeletal Research - Project Summary/Abstract

The musculoskeletal system has both mechanical and biological functions. It generates, transmits, and supports forces, and it regulates organ-level homeostasis and whole-body metabolism. The mechanics and biology of the musculoskeletal system are inextricably intertwined and long-ranging.

Mechanical cues, molecular signals, and cell interactions affect each other across multiple scales, from the body to organ, tissue, cell, and molecule levels. Progress in musculoskeletal research depends on addressing the mechanics and biology of adjacent organs and evaluating the effects of injury as well as aging.

Identifying the mechanisms underlying musculoskeletal health and musculoskeletal disorders (e.g., osteoarthritis, osteoporosis, muscle wasting, post-traumatic repair, degeneration) therefore requires a research paradigm that addresses the synergies within the musculoskeletal system and combines both mechanical and biological approaches across multiple scales.

The Delaware Center for Musculoskeletal Research (DCMR) will support basic and preclinical research on the central theme of musculoskeletal health. This includes understanding the mechanisms by which physical and biological cues influence tissue structure and normal function and dysfunction, and identifying potential therapeutic interventions.

The proposed DCMR will:

AIM 1: Accelerate fundamental musculoskeletal research by supporting synergistic and multidisciplinary research projects.

AIM 2: Galvanize capabilities for musculoskeletal research by establishing a multiscale assessments research core.

AIM 3: Amplify the impact of musculoskeletal research through faculty mentoring, expansion, and retention.

Completion of this 5-year Phase I COBRE will build cross-cutting and synergistic research collaborations across multi-scale and multidisciplinary research projects and establish a state-of-the-art research core.

The DCMR, which will focus on fundamental discovery and preclinical research, will complement the outstanding translational and clinical musculoskeletal research programs at Delaware, creating a comprehensive basic-to-clinical research pipeline at UD.

Through fostering cross-cutting and convergent research partnerships, the DCMR aims to substantially reduce the burden of musculoskeletal disorders and improve musculoskeletal health.
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Place of Performance
Delaware United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the End Date has been extended from 01/31/26 to 01/31/27 and the total obligations have increased 510% from $2,350,090 to $14,347,054.
University Of Delaware was awarded DCMR: Multidisciplinary Musculoskeletal Research Project Grant P20GM139760 worth $14,347,054 from the National Institute of General Medical Sciences in February 2021 with work to be completed primarily in Delaware United States. The grant has a duration of 6 years and was awarded through assistance program 93.859 Biomedical Research and Research Training. The Project Grant was awarded through grant opportunity Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional).

Status
(Ongoing)

Last Modified 12/19/25

Period of Performance
2/15/21
Start Date
1/31/27
End Date
82.0% Complete

Funding Split
$14.3M
Federal Obligation
$0.0
Non-Federal Obligation
$14.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to P20GM139760

Subgrant Awards

Disclosed subgrants for P20GM139760

Transaction History

Modifications to P20GM139760

Additional Detail

Award ID FAIN
P20GM139760
SAI Number
P20GM139760-1090702741
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
T72NHKM259N3
Awardee CAGE
015X1
Performance District
DE-00
Senators
Thomas Carper
Christopher Coons

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) Health research and training Grants, subsidies, and contributions (41.0) $5,831,063 95%
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $306,774 5%
Modified: 12/19/25